(Q34726676)

4 August 2017

title

Bradykinin is a mediator of anaphylactoid reactions during hemodialysis with AN69 membranes (English)

1 reference

4 August 2017

Verresen L

1

1 reference

4 August 2017

Fink E

series ordinal

2

1 reference

4 August 2017

Lemke HD

series ordinal

3

1 reference

4 August 2017

Vanrenterghem Y

series ordinal

4

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 May 1994

1 reference

4 August 2017

1 reference

4 August 2017

volume

45

1 reference

4 August 2017

issue

5

1 reference

4 August 2017

page(s)

1497-1503

1 reference

Allergy to ethylene oxide in chronic hemodialysis patients

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.195

7 January 2021

Complement Activation and Hypersensitivity Reactions to Dialysis Membranes

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.195

7 January 2021

Dialysis-Associated Adverse Reactions with High-Flux Membranes and Microbial Contamination of Liquid Bicarbonate Concentrate

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.195

7 January 2021

Angiotensin-converting-enzyme inhibitors and anaphylactoid reactions to high-flux membrane dialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.195

7 January 2021

High-permeable membranes and hypersensitivity-like reactions: role of dialysis fluid contamination

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.195

7 January 2021

Anaphylactoid reactions during hemodialysis on AN69 membranes in patients receiving ACE inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.195

7 January 2021

Anaphylactoid reactions in hemodialysis patients treated with the AN69 dialyzer

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.195

7 January 2021

Anaphylactoid reactions during hemodialysis and hemofiltration: role of associating AN69 membrane and angiotensin I-converting enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.195

7 January 2021

The interrelationship of coagulation of plasma and release of peptides

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.195

7 January 2021

Renin- and non-renin–mediated antihypertensive actions of converting enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.195

7 January 2021

Anaphylactoid reactions associated with reuse of hollow-fiber hemodialyzers and ACE inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.195

7 January 2021

Direct evidence for Hageman factor (factor XII) activation by bacterial lipopolysaccharides (endotoxins).

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.195

7 January 2021

Prekallikrein activation and high-molecular-weight kininogen consumption in hereditary angioedema

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.195

7 January 2021

Clinical profile of angioedema associated with angiotensin converting-enzyme inhibition

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.195

7 January 2021

Familial carboxypeptidase N deficiency

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.195

7 January 2021

Bradykinin-mediated effects of ACE inhibition.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.195

7 January 2021

L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.195

7 January 2021

Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.195

7 January 2021

Identifiers

DOI

10.1038/KI.1994.195

1 reference

Dimensions Publication ID

4 August 2017

1001431834

0 references

1 reference